Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma

A. Petrillo; S. Lorenzen; H. W.M. van Laarhoven

doi:10.1016/j.esmoop.2022.100613

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma

A. Petrillo^*
, S. Lorenzen
, H. W.M. van Laarhoven

^*Corresponding author for this work

Ospedale del Mare
Technical University of Munich

Research output: Contribution to journal › Comment/Letter to the editor › Academic

24 Downloads (Pure)

Original language	English
Article number	100613
Journal	ESMO OPEN
Volume	7
Issue number	6
DOIs	https://doi.org/10.1016/j.esmoop.2022.100613
Publication status	Published - Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.esmoop.2022.100613

Controversies-in-upper-gastrointestinal-oncology.pdfFinal published version, 116 KBLicence: CC BY

Cite this

@article{8b27d63855614b389dc48f0534ee3504,

title = "Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma",

author = "A. Petrillo and S. Lorenzen and \{van Laarhoven\}, \{H. W.M.\}",

year = "2022",

month = dec,

doi = "10.1016/j.esmoop.2022.100613",

language = "English",

volume = "7",

journal = "ESMO OPEN",

issn = "2059-7029",

publisher = "BMJ Publishing Group",

number = "6",

}

TY - JOUR

T1 - Controversies in upper gastrointestinal oncology

T2 - neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma

AU - Petrillo, A.

AU - Lorenzen, S.

AU - van Laarhoven, H. W.M.

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85141343809

U2 - 10.1016/j.esmoop.2022.100613

DO - 10.1016/j.esmoop.2022.100613

M3 - Comment/Letter to the editor

C2 - 36356415

AN - SCOPUS:85141343809

SN - 2059-7029

VL - 7

JO - ESMO OPEN

JF - ESMO OPEN

IS - 6

M1 - 100613

ER -

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma

UN SDGs

Access to Document

Other files and links

Cite this